These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1750433)

  • 41. Anticonvulsant hypersensitivity syndrome with marked eosinophilia in treatment of diabetic neuropathy.
    Yamada N; Kaneko K; Saito Y; Tatsuno I
    Diabetes Care; 2002 Jun; 25(6):1099-100. PubMed ID: 12032126
    [No Abstract]   [Full Text] [Related]  

  • 42. Evaluation of a lymphocyte transformation test and cytokine detection assay to identify phenytoin and carbamazepine provoked DRESS or SJS/TEN in epilepsy patients.
    Kumkamthornkul P; Udnaen S; Tansit T; Tuchinda P; Srinoulprasert Y
    Int Immunopharmacol; 2018 Oct; 63():204-210. PubMed ID: 30103195
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anticonvulsant hypersensitivity syndrome: lymphocyte toxicity assay for the confirmation of diagnosis and risk assessment.
    Bavdekar SB; Muranjan MN; Gogtay NJ; Kantharia V; Kshirsagar NA
    Ann Pharmacother; 2004 Oct; 38(10):1648-50. PubMed ID: 15304627
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Side effects of phenobarbital in epilepsy: a systematic review.
    Zhang LL; Zeng LN; Li YP
    Epileptic Disord; 2011 Dec; 13(4):349-65. PubMed ID: 21926048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study.
    Tennis P; Stern RS
    Neurology; 1997 Aug; 49(2):542-6. PubMed ID: 9270593
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anticonvulsant hypersensitivity syndrome associated with Bellamine S, a therapy for menopausal symptoms.
    Turner RB; Kim CC; Streams BN; Culpepper K; Haynes HA
    J Am Acad Dermatol; 2004 May; 50(5 Suppl):S86-9. PubMed ID: 15097937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DRESS syndrome associated with carbamazepine and phenytoin.
    Allam JP; Paus T; Reichel C; Bieber T; Novak N
    Eur J Dermatol; 2004; 14(5):339-42. PubMed ID: 15358574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anticonvulsant hypersensitivity: an unfortunate case of triple exposure to phenytoin.
    Brown CE; Smith GD; Coniglione T
    J Fam Pract; 1997 Nov; 45(5):434-7. PubMed ID: 9374970
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human anti-endoplasmic reticulum autoantibodies produced in aromatic anticonvulsant hypersensitivity reactions recognise rodent CYP3A proteins and a similarly regulated human P450 enzyme(s).
    Riley RJ; Smith G; Wolf CR; Cook VA; Leeder JS
    Biochem Biophys Res Commun; 1993 Feb; 191(1):32-40. PubMed ID: 8447835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anticonvulsant usage is associated with an increased risk of procarbazine hypersensitivity reactions in patients with brain tumors.
    Lehmann DF; Hurteau TE; Newman N; Coyle TE
    Clin Pharmacol Ther; 1997 Aug; 62(2):225-9. PubMed ID: 9284859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenytoin-carbamazepine cross-sensitivity.
    Reents SB; Luginbuhl WE; Davis SM
    DICP; 1989 Mar; 23(3):235-6. PubMed ID: 2718502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence of Stevens-Johnson syndrome following combination drug use of allopurinol, carbamazepine and phenytoin in Taiwan: A case-control study.
    Syu FK; Pan HY; Chuang PC; Huang YS; Cheng CY; Cheng FJ
    J Dermatol; 2018 Sep; 45(9):1080-1087. PubMed ID: 29963717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DRESS Syndrome Presents as Leukoencephalopathy.
    Tonekaboni SH; Jafari N; Chavoshzadeh Z; Shamsian BS; Rezaei N
    Turk J Pediatr; 2015; 57(5):541-4. PubMed ID: 27411428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anticonvulsant hypersensitivity syndrome: treatment with corticosteroids and intravenous immunoglobulin.
    Mostella J; Pieroni R; Jones R; Finch CK
    South Med J; 2004 Mar; 97(3):319-21. PubMed ID: 15043348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug rash with eosinophilia and systemic symptoms syndrome associated with use of phenytoin, divalproex sodium, and phenobarbital.
    Brizendine CE; Naik PJ
    Am J Health Syst Pharm; 2013 Mar; 70(6):507-10. PubMed ID: 23456403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hypersensitivity syndrome caused by phenytoins and phenobarbital].
    Fonseca JC; Azulay DR; Rozembau I; Azulay RD
    Med Cutan Ibero Lat Am; 1984; 12(3):187-92. PubMed ID: 6237236
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiepileptic drug-induced hypersensitivity syndrome reactions.
    Krivoy N; Taer M; Neuman MG
    Curr Drug Saf; 2006 Aug; 1(3):289-99. PubMed ID: 18690940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phenytoin hypersensitivity: 38 cases.
    Haruda F
    Neurology; 1979 Nov; 29(11):1480-5. PubMed ID: 574201
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro.
    Sorrell TC; Forbes IJ
    Clin Exp Immunol; 1975 May; 20(2):273-85. PubMed ID: 1212810
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients.
    Babaei A; Eslamai MH
    Int J Clin Pharmacol Ther; 2007 Feb; 45(2):121-5. PubMed ID: 17323792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.